Vivos Therapeutics Inc. (VVOS): Price and Financial Metrics
VVOS Price/Volume Stats
| Current price | $2.53 | 52-week high | $48.79 |
| Prev. close | $2.53 | 52-week low | $2.37 |
| Day low | $2.45 | Volume | 24,900 |
| Day high | $2.54 | Avg. volume | 180,115 |
| 50-day MA | $3.90 | Dividend yield | N/A |
| 200-day MA | $6.64 | Market Cap | 7.54M |
VVOS Stock Price Chart Interactive Chart >
Vivos Therapeutics Inc. (VVOS) Company Bio
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (SDB) comprising mild-to-moderate obstructive sleep apnea (OSA). The company's solutions cover proprietary alternatives for treating mild-to-moderate OSA; craniofacial and anatomical anomalies that are associated with mild-to-moderate OSA. Its treatment for OSA involves specially designed and customized oral appliances and treatment protocols. The company, through its Vivos Integrated Healthcare Network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate OSA. Vivos Therapeutics, Inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. It caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers, and patients in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2007 and is based in Highlands Ranch, Colorado.
Latest VVOS News From Around the Web
Below are the latest news stories about VIVOS THERAPEUTICS INC that investors may wish to consider to help them evaluate VVOS as an investment opportunity.
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”Vivos unites influential women leaders in medicine and dentistry to drive collaboration following first ever FDA 510(k) clearance of an oral device to treat severe OSALITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including mild to severe obstr |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start of the trading week with a look at the biggest pre-market stock movers worth watching on Monday morning! |
Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week. |
Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! |
VVOS Price Returns
| 1-mo | -25.26% |
| 3-mo | -58.73% |
| 6-mo | -26.02% |
| 1-year | -68.37% |
| 3-year | -98.58% |
| 5-year | N/A |
| YTD | -79.66% |
| 2023 | 23.78% |
| 2022 | -82.13% |
| 2021 | -61.93% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...